1. US Food and Drug Administration: FDA Draft Guidance for Industry. Rare Diseases: Common Issues in Drug Development, January 2019.
2. US Food and Drug Administration: Guidance for Industry – Human Gene Therapy for Rare Diseases, January 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/human-gene-therapy-rare-diseases.
3. US Food and Drug Administration: Guidance for Industry. Chemistry, Manufacturing, and Controls (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs), January 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/chemistry-manufacturing-and-control-cmc-information-human-gene-therapy-investigational-new-drug.
4. US Food and Drug Administration: Guidance for FDA Reviewers and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs), April 2008.
5. US Food and Drug Administration: Guidance for Industry – Human Gene Therapy for Hemophilia, January 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/human-gene-therapy-hemophilia.